Lymphoma Clinical Trials in Baltimore

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1423 more
2022-04-06
Apr 6, 2022
N
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
Recruiting
  • Lymphoma
  • +6 more
  • Cytology Specimen Collection Procedure
  • Birmingham, Alabama
  • +139 more
2022-04-05
Apr 5, 2022
J
A Study of PCI-32765 (Ibrutinib) in Combination With Either Bendamustine and Rituximab or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Participants With Previously Treated Indolent Non-Hodgkin Lymphoma
Active, not recruiting
  • Lymphoma
  • Gilbert, Arizona
  • +134 more
2022-03-24
Mar 24, 2022
C
Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant
Active, not recruiting
  • Hematopoietic and Lymphoid System Neoplasm
  • +3 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +3 more
  • Birmingham, Alabama
  • +42 more
2022-03-22
Mar 22, 2022
I
A Study of Itacitinib (INCB039110) in Combination With Ibrutinib in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Active, not recruiting
  • Lymphoma
  • Scottsdale, Arizona
  • +20 more
2022-03-08
Mar 8, 2022
I
A Phase 2 Safety and Efficacy Study of INCB050465 in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (CITADEL-202) - 2021
Completed
Has Results
  • Lymphoma
  • Birmingham, Alabama
  • +69 more
2022-02-28
Feb 28, 2022
E
Bendamustine Hydrochloride and Rituximab With or Without Bortezomib Followed by Rituximab With or Without Lenalidomide in Treating Patients With High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma
Active, not recruiting
Has Results
  • Lymphoma
  • rituximab
  • +3 more
  • Greenbrae, California
  • +226 more
2022-03-07
Mar 7, 2022
B
A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase - 2021
Completed
Has Results
  • Lymphoma
  • Acute Lymphoblastic Leukemia
  • Apixaban
  • No systemic anticoagulant prophylaxis
  • Phoenix, Arizona
  • +95 more
2022-02-10
Feb 10, 2022
C
Collecting and Storing Tissue From Young Patients With Cancer
Recruiting
  • Acute Lymphoblastic Leukemia
  • +13 more
  • Cytology Specimen Collection Procedure
  • Laboratory Biomarker Analysis
  • Birmingham, Alabama
  • +68 more
2022-03-03
Mar 3, 2022
N
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction
Active, not recruiting
  • Glioma
  • +49 more
  • Duarte, California
  • +11 more
2022-03-01
Mar 1, 2022
C
HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide
Recruiting
  • Acute Lymphoblastic Leukemia
  • +7 more
  • Duarte, California
  • +16 more
2022-02-25
Feb 25, 2022
S
Resiliency in Older Adults Undergoing Bone Marrow Transplant
Recruiting
  • Leukemia
  • +5 more
  • Bone Marrow Transplant (BMT)
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
2022-02-14
Feb 14, 2022
I
Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers - 2020
Completed
Has Results
  • Microsatellite-instability (MSI) High Colorectal Cancer (CRC)
  • +13 more
  • La Jolla, California
  • +23 more
2022-02-11
Feb 11, 2022
I
A Study of INCB050465 in Relapsed or Refractory Follicular Lymphoma
Active, not recruiting
Has Results
  • Lymphoma
  • Phoenix, Arizona
  • +82 more
2022-01-14
Jan 14, 2022
A
Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas
Active, not recruiting
  • Solid Tumors
  • Lymphoma
  • Birmingham, Alabama
  • +68 more
2022-01-24
Jan 24, 2022
M
Autologous Transplant in HIV Patients (BMT CTN 0803) - 2016
Completed
Has Results
  • Lymphoma
  • HIV
  • Autologous transplant
  • +4 more
  • Duarte, California
  • +15 more
2022-01-25
Jan 25, 2022
S
S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma
Active, not recruiting
Has Results
  • Lymphoma
  • Nonneoplastic Condition
  • bleomycin sulfate
  • +11 more
  • Tucson, Arizona
  • +422 more
2022-01-19
Jan 19, 2022
E
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Active, not recruiting
  • Lymphoma
  • +2 more
  • rituximab
  • +3 more
  • Anchorage, Alaska
  • +417 more
2021-12-29
Dec 29, 2021
A
Response-Based Therapy Assessed By PET Scan in Treating Patients With Bulky Stage I and Stage II Classical Hodgkin Lymphoma - 2021
Completed
Has Results
  • Lymphoma
  • Saint Helena, California
  • +54 more
2021-11-05
Nov 5, 2021
H
A Study of Polatuzumab Vedotin (DCDS4501A) in Combination With Rituximab or Obinutuzumab Plus Bendamustine in Participants With Relapsed or Refractory Follicular or Diffuse Large B-Cell Lymphoma - 2021
Completed
  • Lymphoma
  • Birmingham, Alabama
  • +61 more
2021-11-30
Nov 30, 2021
R
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Active, not recruiting
Has Results
  • Chemotherapeutic Agent Toxicity
  • +4 more
  • Rituximab
  • +5 more
  • Birmingham, Alabama
  • +44 more
2021-11-02
Nov 2, 2021
M
TAC/MTX vs. TAC/MMF/PTCY for Prevention of Graft-versus-Host Disease and Microbiome and Immune Reconstitution Study (BMT CTN 1703/1801)
Active, not recruiting
  • Acute Leukemia
  • +3 more
  • Mobilized Peripheral Blood Stem Cell graft with Tacrolimus/Methotrexate
  • +5 more
  • Birmingham, Alabama
  • +38 more
2021-10-25
Oct 25, 2021
M
Rituximab Followed by Combination Chemotherapy in Treating Patients With Refractory or Recurrent Non-Hodgkin's Lymphoma
Withdrawn
  • Lymphoma
  • rituximab
  • +7 more
  • Washington, District of Columbia
  • +1 more
2021-10-19
Oct 19, 2021
C
Study of ACTR707 in Combination With Rituximab in Subjects With Relapsed or Refractory B Cell Lymphoma - 2020
Terminated
  • Lymphoma
  • ACTR707
  • rituximab
  • Gilbert, Arizona
  • +10 more
2021-10-04
Oct 4, 2021
S
S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Newly Diagnosed Non-Hodgkin's Lymphoma
Active, not recruiting
Has Results
  • Lymphoma
  • rituximab
  • +5 more
  • Anchorage, Alaska
  • +258 more
2021-09-21
Sep 21, 2021